We anticipate that DACH1 mutations result in loss of transcriptional repression of these regulators resulting in uncontrolled cell cycle progression in endometrial cancer, similar to DACH1’s control of the cell cycle via cyclin D1 in breast cancer [8, 22]. This evidence concerns the gene DACH1 and breast carcinoma.